SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
119 hedge funds and large institutions have $229M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13% less funds holding
Funds holding: 136 → 119 (-17)
55% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 29
Holders
119
Holding in Top 10
1
Calls
$615K
Puts
$416K
Top Buyers
| 1 | +$15.4M | |
| 2 | +$3.02M | |
| 3 | +$2.85M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$2.46M |
| 5 |
RA
Royce & Associates
New York
|
+$2.32M |
Top Sellers
| 1 | -$9.61M | |
| 2 | -$3.59M | |
| 3 | -$2.45M | |
| 4 |
Morgan Stanley
New York
|
-$2.44M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.35M |